全文1752字,阅读约需5分钟,帮我划重点划重点01拜耳计划在本土赋能8至10家初创企业,重点关注细胞和基因疗法、肿瘤以及新技术平台等前沿创新领域。02中国生物医药市场规模跃居全球第二,医药创新管线数量跻身全球第二梯队前列。03为此,拜耳将继续通过本地研发中心和外部合作双重动力推动创新,如已与清华大学及北京大学累计开展超100个联合研究项目。04此外,拜耳还将持续优化在华生产、研发的布局,提高患者...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.